Total submissions: 1
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
ARUP Laboratories, |
RCV001802479 | SCV002048611 | pathogenic | Hereditary factor VIII deficiency disease | 2021-01-22 | criteria provided, single submitter | clinical testing | The F8 c.5449C>T; p.Gln1817Ter variant is reported in the literature in an individual affected with severe hemophilia A (Pinto 2016). This variant is only observed on one allele in the Genome Aggregation Database, indicating it is not a common polymorphism. This variant induces an early termination codon and is predicted to result in a truncated protein or mRNA subject to nonsense-mediated decay. Based on available information, this variant is considered to be pathogenic. References: Pinto P et al. F8 gene mutation profile in Indian hemophilia A patients: Identification of 23 novel mutations and factor VIII inhibitor risk association. Mutat Res. 2016 Apr;786:27-33. |